Quote | Viatris Inc. (NASDAQ:VTRS)
Last: | $11.12 |
---|---|
Change Percent: | -0.18% |
Open: | $11.12 |
Close: | $11.12 |
High: | $11.25 |
Low: | $11.07 |
Volume: | 3,464,085 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
News | Viatris Inc. (NASDAQ:VTRS)
2024-04-17 09:26:31 ET More on CVS Health CVS Health: Seizing Opportunity Amid Recent Declines CVS Health: Good Management Is Keeping Their Promises CVS Health: Here Comes The Floor - Inherent Undervaluation Triggers Great Upside Potential Dividend Roundup: P...
Viatris to Report First Quarter 2024 Financial Results on May 9, 2024 PR Newswire PITTSBURGH , April 16, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will report its first quarter 2024 financial results on Thursday, May 9, 2024 , before the open ...
Message Board Posts | Viatris Inc. (NASDAQ:VTRS)
Subject | By | Source | When |
---|---|---|---|
$VTRS reports 4Q22 resultsissues 2023 guidance: | DewDiligence | investorshub | 02/27/2023 5:04:40 PM |
Nothing that's been publicly disclosed. | DewDiligence | investorshub | 02/27/2023 5:03:45 PM |
VTRS names new CEO: | DewDiligence | investorshub | 02/27/2023 5:03:22 PM |
VTRS anything going on? Related to $RVNC? eom | procqw2 | investorshub | 10/11/2022 3:02:32 PM |
VTRS anything going on? Related to $RVNC? eom | procqw2 | investorshub | 10/11/2022 3:02:28 PM |
News, Short Squeeze, Breakout and More Instantly...
Viatris Inc. Company Name:
VTRS Stock Symbol:
NASDAQ Market:
Viatris to Report First Quarter 2024 Financial Results on May 9, 2024 PR Newswire PITTSBURGH , April 16, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will report its first quarter 2024 financial results on Thursday, May 9, 2024 , before the open ...
Viatris Appoints Corinne Le Goff as Chief Commercial Officer PR Newswire PITTSBURGH , April 15, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that Corinne Le Goff has joined the company as Chief Commercial ...
Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone® 20 mg/mL Once-Daily in Canada Canada NewsWire New generic Multiple Sclerosis treatment option, Pr Glatiramer Acetate Injection 20 mg/mL for once-daily injection, available for one of the larg...